Temozolomide
RFF -0208
Approved small_molecule completed
Quick answer
Temozolomide for Brain Neoplasms, Malignant, Primary is a Approved program (small_molecule) at Monte Rosa Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Monte Rosa Therapeutics
- Indication
- Brain Neoplasms, Malignant, Primary
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed